Helus Pharma News and Activities

Helus Pharma is a company listed under the stock ticker Help (CA).

Acquisition, funding and merger involving Helus Pharma.

• Cybin has changed its company name to Helus Pharma (posted on February 13 2026).
• Helus Pharma is now listed under ticker HELP. (posted on February 12 2026).
• Helus Pharma has filed its IPO. Its stock ticker will be HELP. (posted on December 31 2025).

View the org chart displaying its 27 main executives

Most searched biographies at Helus Pharma

• Eric So, Executive Chairman of the Board and Interim Chief Executi...
• Eric Hoskins, Director
• Mark Lawson, Director

Popular executive movements at Helus Pharma

• Eric So who was Executive Chairman of the Board, becomes Executive Chairman of the Board and Interim Chief Executive Officer  (posted on April 21 2026).
• Michael Cola, Chief Executive Officer, has left the company  (posted on April 21 2026).
• Ken Kramer has joined the company as Head of Medical Affairs  (posted on April 17 2026).

Click here to view some more movements at Helus Pharma

Create your alert
to follow the executive moves at Helus Pharma.

Helus Pharma has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).
• Novartis has announced the acquisition of Myricx Bio  (posted on July 6 2026).
• Ipsen has announced the acquisition of Kartos Therapeutics  (posted on July 3 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by Helus Pharma

• Helus Pharma™ Announces Closing of US$50 Million Underwritten Offering - Thu, 06/25/2026 - 09:28
• Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results - Mon, 06/29/2026 - 07:40
• Helus Pharma™ Announces US$50 Million Underwritten Offering - Wed, 06/24/2026 - 06:01
• Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress - Wed, 06/24/2026 - 06:00
• Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference - Thu, 06/11/2026 - 07:30
• Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York - Mon, 06/01/2026 - 07:30
• Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference - Thu, 04/30/2026 - 07:30
• News | Helus Pharma
• News | Helus Pharma
• News | Helus Pharma
• View more press releases Close

Social media about Helus Pharma

• Helus Pharma on Wikipedia, Google News & Yahoo Finance
• Helus Pharma on LinkedIn, X (Twitter) & YouTube